| CCC | I435 |
Detroit 562 cell line is a human pharyngeal squamous cell carcinoma cell line that was derived from a tumor specimen obtained from a patient with laryngeal cancer. The Detroit 562 cell line was established in the 1970s by J. Rheinwald and H. Green at the Massachusetts Institute of Technology (MIT).
Detroit 562 cells exhibit characteristics typical of squamous epithelial cells and have been widely utilized in cancer research, particularly in studies focusing on head and neck cancers, as well as in investigating various aspects of cellular biology, including cell signaling pathways, gene expression, and drug sensitivity testing.
Detroit 562 cell line has been instrumental in advancing our understanding of the molecular mechanisms underlying the development and progression of head and neck cancers, providing researchers with a valuable tool for studying tumor biology, drug resistance mechanisms, and potential therapeutic interventions.
Furthermore, Detroit 562 cells have been used to investigate the effects of various chemical and biological agents on cancer cell growth and survival, as well as to screen potential anti-cancer drugs and therapies targeting squamous cell carcinomas and related malignancies.
Organism species: Homo sapiens (Human)
| CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
| Cells | CSI435Hu11 | Human Detroit562 Pleural Fluid Oropharyngeal Carcinoma Cells (Detroit562) | For research use only. It is not approved for human or animal use, or for applications in in vitro diganostic procedures. |
| Extracts | n/a | Extract of Detroit562 Pleural Fluid Oropharyngeal Carcinoma Cells (Detroit562) | Total Protein/DNA/RNA Extract Customized Service Offer |
| Mediums | n/a | Medium for Detroit562 Pleural Fluid Oropharyngeal Carcinoma Cells (Detroit562) (If Necessary) | Cell Culture Medium Customized Service Offer |